Published in J Immunol on January 01, 1966
Factors modifying host resistance to viral infection. 3. Effect of whole body x-irradiation on experimental encephalomyocarditis virus infection in mice. J Exp Med (1968) 1.61
Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness. J Exp Med (1968) 1.36
Production of interferon by alveolar macrophages. J Bacteriol (1966) 1.20
Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus. Infect Immun (1975) 1.19
The effect of an interferon inducer on influenza virus. Bull World Health Organ (1969) 1.10
Inactivated smallpox vaccine. A comparison of inactivation methods. J Hyg (Lond) (1970) 1.02
Production of interferon in mice: effect of altered gaseous environments. Appl Microbiol (1968) 1.02
Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice. Antimicrob Agents Chemother (1976) 0.96
Murine cytomegalovirus: induction of and sensitivity to interferon in vitro. Infect Immun (1975) 0.93
A sensitive radioimmunoassay for circulating alpha-interferon in the plasma of healthy children and patients with measles virus infection. Clin Exp Immunol (1988) 0.90
Enhancement of bacterial infections in mice by newcastle disease virus. Infect Immun (1971) 0.86
Target-organ treatment of neurotropic virus disease with interferon inducers. Infect Immun (1972) 0.85
Effect of an immunosuppressive agent, cyclophosphamide, on chronic lactic dehydrogenase virus viremia of mice. Infect Immun (1971) 0.84
Interferon system in mice infected with the scrapie agent. Infect Immun (1972) 0.83
Effectiveness of therapy with a multistranded synthetic polynucleotide complex against a murine sarcoma virus. Appl Microbiol (1969) 0.81
Rabies vaccines and interferon. J Hyg (Lond) (1972) 0.79
Mink parvoviruses and interferons: in vitro studies. J Virol (1986) 0.79
Mouse interferon in ascitic fluids. Appl Microbiol (1974) 0.75
Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives. Proc Natl Acad Sci U S A (1971) 5.31
Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci U S A (1986) 4.43
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
Replication of semliki forest virus: three forms of viral RNA produced during infection. Proc Natl Acad Sci U S A (1966) 3.23
Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus. J Virol (1985) 3.06
Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol (1968) 3.04
Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol (1994) 2.99
Statistical considerations for linkage analysis using recombinant inbred strains and backcrosses. Proc Natl Acad Sci U S A (1986) 2.60
Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child. Int J Cancer (1966) 2.51
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
Cytoplasmic fractions associated with Semliki Forest virus ribonucleic acid replication. J Virol (1967) 2.29
Antiviral activity of interferons. Bacteriol Rev (1977) 2.25
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
The effect of interferon on SV-40 T antigen production in SV-40-transformed cells. Virology (1967) 2.13
Analysis of arbovirus ribonucleic acid forms by polyacrylamide gel electrophoresis. J Virol (1971) 2.10
Cloning and characterization of an envelope-specific probe from xenotropic murine leukemia proviral DNA. J Virol (1982) 2.09
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science (1968) 2.02
Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J Virol (1972) 2.00
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98
Membrane-associated replication complex in arbovirus infection. J Virol (1972) 1.83
Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med (1972) 1.79
Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum (1998) 1.79
High interferon producing line of transformed murine cells. J Gen Virol (1972) 1.79
Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res Hum Retroviruses (1996) 1.74
The epidemiology of childhood psychiatric disorders: prevalence findings from recent studies. J Am Acad Child Adolesc Psychiatry (1990) 1.73
Recombinant human gamma interferon inhibits simian malaria. Infect Immun (1986) 1.71
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis (1973) 1.70
Interferons with special emphasis on the immune system. Adv Immunol (1983) 1.69
Membrane binding of input arbovirus ribonucleic acid: effect of interferon or cycloheximide. J Virol (1970) 1.66
Inhibition of interferon action by puromycin. J Immunol (1965) 1.65
Protein synthesis directed by an arbovirus. J Virol (1968) 1.63
Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol (1981) 1.62
Recurrent digital ischemia due to thrombosis of the persistent median artery. Plast Reconstr Surg (1997) 1.61
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Simian virus 40-specific ribosome-binding proteins induced by a nondefective adenovirus 2-simian virus 40 hybrid. J Virol (1977) 1.59
Organization and stability of endogenous xenotropic murine leukemia virus proviral DNA in mouse genomes. J Virol (1983) 1.57
Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol (2000) 1.55
Lysyl oxidase and rrg messenger RNA. Science (1991) 1.55
Specific membranous structures associated with the replication of group A arboviruses. J Virol (1972) 1.54
Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003. Epidemiol Infect (2007) 1.54
A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med (1990) 1.53
Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science (1990) 1.53
The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc Natl Acad Sci U S A (1965) 1.52
General considerations of the interferon system. Tex Rep Biol Med (1977) 1.52
A unique sequence related to the ecotropic murine leukemia virus is associated with the Fv-4 resistance gene. Proc Natl Acad Sci U S A (1984) 1.51
Replicative intermediate of an arbovirus. J Virol (1968) 1.51
Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon. Proc Natl Acad Sci U S A (1974) 1.50
Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. J Virol (1975) 1.49
Effect of interferon treatment on interferon production. J Immunol (1966) 1.49
Bacteremia after liver biopsy. Arch Intern Med (1973) 1.49
IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.49
European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine (2003) 1.48
Internal stabilization of autogenous rib cartilage grafts in rhinoplasty: a barrier to cartilage warping. Plast Reconstr Surg (1997) 1.48
Genetic mapping of the mouse c-fms proto-oncogene to chromosome 18. J Virol (1988) 1.48
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. Proc Soc Exp Biol Med (1971) 1.47
Potentiation of human interferon production by superinduction. J Natl Cancer Inst (1971) 1.47
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci U S A (1982) 1.46
Interferon binding: the first step in establishment of antiviral activity. Science (1967) 1.45
Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction. J Immunol (1990) 1.44
Variation in the number of copies and in the genomic organization of ecotropic murine leukemia virus proviral sequences in sublines of AKR mice. J Virol (1982) 1.44
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst (1976) 1.42
Identification of a subpopulation of mouse lymphoid cells required for interferon production after stimulation with mitogens. J Immunol (1974) 1.41
Unexpectedly rapid action of human interferon in physiological conditions. Nature (1975) 1.41
Periodic fever. Diagnostic and therapeutic problems. JAMA (1974) 1.40
Caring for severely emotionally disturbed children and youth. Principles for a system of care. Child Today (1988) 1.39
An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J Virol (1996) 1.38
Evaluation of an interferon inducer in viral respiratory disease. JAMA (1972) 1.37
Internal organization of endogenous proviral DNAs of xenotropic murine leukemia viruses. J Virol (1982) 1.36
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature (1976) 1.35
Structural and nonstructural proteins of an arbovirus. J Virol (1968) 1.33
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia (2008) 1.33
Interferon-induced transfer of viral resistance between animal cells. Nature (1977) 1.31
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene (2010) 1.31
The 1970 epidemic of diphtheria in San Antonio. Ann Intern Med (1971) 1.31
Interferon inhibits mouse leukaemia virus release: an electron microscope study. J Gen Virol (1977) 1.31
Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide. J Exp Med (1972) 1.30
Effect of interferon on early interferon production. Science (1966) 1.30
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Sensitivity of common respiratory viruses to an interferon inducer in human cells. Lancet (1969) 1.29
Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene. Biochem Biophys Res Commun (1984) 1.29
Actinomycin D: inhibition of phospholipid synthesis in chick embryo cells. Science (1968) 1.28
Interferon action on parental Semliki forest virus ribonucleic acid. J Virol (1967) 1.28
Growth of Toxoplasma gondii in various tissue cultures treated with In-Cn or interferon. Proc Soc Exp Biol Med (1973) 1.26
Role of interferon in streptococcal infection in the mouse. Microb Pathog (1986) 1.24
Human lymphoblastoid interferon. Large scale production and partial purification. J Biol Chem (1977) 1.24
Physical, morphological, and biochemical alterations in the membrane of AKR mouse cells after interferon treatment. Proc Natl Acad Sci U S A (1978) 1.23